These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 9304276)

  • 1. [Molecular biology of prostate carcinoma].
    Urologe A; 1997 May; 36(3 Suppl Molekular):1-8. PubMed ID: 9304276
    [No Abstract]   [Full Text] [Related]  

  • 2. hCAP-D3 expression marks a prostate cancer subtype with favorable clinical behavior and androgen signaling signature.
    Lapointe J; Malhotra S; Higgins JP; Bair E; Thompson M; Salari K; Giacomini CP; Ferrari M; Montgomery K; Tibshirani R; van de Rijn M; Brooks JD; Pollack JR
    Am J Surg Pathol; 2008 Feb; 32(2):205-9. PubMed ID: 18223322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular biology of prostate-cancer pathogenesis.
    Shand RL; Gelmann EP
    Curr Opin Urol; 2006 May; 16(3):123-31. PubMed ID: 16679847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular biology of brain tumors.
    Wu JK; Naber SP
    Neurosurg Clin N Am; 1994 Jan; 5(1):127-33. PubMed ID: 8124087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression of genes converting adrenal androgens to testosterone in androgen-independent prostate cancer.
    Stanbrough M; Bubley GJ; Ross K; Golub TR; Rubin MA; Penning TM; Febbo PG; Balk SP
    Cancer Res; 2006 Mar; 66(5):2815-25. PubMed ID: 16510604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Molecular analysis for prostate cancer].
    Ueda T; Suzuki H; Ichikawa T
    Nihon Rinsho; 2005 Feb; 63(2):213-7. PubMed ID: 15714968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Research at the Ulm University in prostate cancer].
    Rinnab L; Cronauer M; Spindler D; Hautmann RE; Küfer R
    Urologe A; 2007 Sep; 46(9):1071-7. PubMed ID: 17628778
    [No Abstract]   [Full Text] [Related]  

  • 8. Amyloid precursor protein is a primary androgen target gene that promotes prostate cancer growth.
    Takayama K; Tsutsumi S; Suzuki T; Horie-Inoue K; Ikeda K; Kaneshiro K; Fujimura T; Kumagai J; Urano T; Sakaki Y; Shirahige K; Sasano H; Takahashi S; Kitamura T; Ouchi Y; Aburatani H; Inoue S
    Cancer Res; 2009 Jan; 69(1):137-42. PubMed ID: 19117996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of mu-crystallin as an androgen-regulated gene in human prostate cancer.
    Malinowska K; Cavarretta IT; Susani M; Wrulich OA; Uberall F; Kenner L; Culig Z
    Prostate; 2009 Jul; 69(10):1109-18. PubMed ID: 19353593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression profile of an androgen regulated prostate specific homeobox gene NKX3.1 in primary prostate cancer.
    Xu LL; Srikantan V; Sesterhenn IA; Augustus M; Dean R; Moul JW; Carter KC; Srivastava S
    J Urol; 2000 Mar; 163(3):972-9. PubMed ID: 10688034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic alterations in prostate adenocarcinoma.
    Prendergast NJ; Walther PJ
    Surg Oncol Clin N Am; 1995 Apr; 4(2):241-55. PubMed ID: 7796284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1.
    Zaia A; Fraizer GC; Piantanelli L; Saunders GF
    Anticancer Res; 2001; 21(1A):1-10. PubMed ID: 11299720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular biologic aspects of human prostatic carcinoma.
    Netto GJ; Humphrey PA
    Am J Clin Pathol; 1994 Oct; 102(4 Suppl 1):S57-64. PubMed ID: 7942612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal analysis of androgen deprivation of prostate cancer cells identifies pathways to androgen independence.
    D'Antonio JM; Ma C; Monzon FA; Pflug BR
    Prostate; 2008 May; 68(7):698-714. PubMed ID: 18302219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cancer--a disease of the genes].
    Sauter G
    Praxis (Bern 1994); 1998 Apr; 87(16):535-7. PubMed ID: 9600016
    [No Abstract]   [Full Text] [Related]  

  • 16. Validation of molecular targets in prostate cancer.
    Schalken JA
    BJU Int; 2005 Dec; 96 Suppl 2():23-9. PubMed ID: 16359435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PC3, but not DU145, human prostate cancer cells retain the coregulators required for tumor suppressor ability of androgen receptor.
    Litvinov IV; Antony L; Dalrymple SL; Becker R; Cheng L; Isaacs JT
    Prostate; 2006 Sep; 66(12):1329-38. PubMed ID: 16835890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prostate cancer: cytogenetic and molecular biology principles].
    Strohmeyer T; Effert P
    Med Klin (Munich); 1993 Aug; 88(8):482-4. PubMed ID: 8413050
    [No Abstract]   [Full Text] [Related]  

  • 19. Differently regulated androgen receptor transcriptional complex in prostate cancer compared with normal prostate.
    Kinoshita M; Nakagawa T; Shimizu A; Katsuoka Y
    Int J Urol; 2005 Apr; 12(4):390-7. PubMed ID: 15948728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased expression of heparin binding EGF (HB-EGF), amphiregulin, TGF alpha and epiregulin in androgen-independent prostate cancer cell lines.
    Tørring N; Jørgensen PE; Sørensen BS; Nexø E
    Anticancer Res; 2000; 20(1A):91-5. PubMed ID: 10769639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.